Table 2 Baseline characteristics of 200 patients with mild to moderate persistent asthma who were randomised to Internet group or usual care group
Well controlled asthma | Partly controlled asthma | Uncontrolled asthma | ||||
|---|---|---|---|---|---|---|
Usual Care group (n = 38) | Internet group (n = 37) | Usual Care group (n = 33) | Internet group (n = 38) | Usual Care group (n = 28) | Internet group (n = 26) | |
Age, mean yr (SD) | 37.6 (7.5) | 35.8 (8.9) | 36.3 (10.1) | 35.5 (9.7) | 36.0 (6.9) | 36.9 (7.6) |
Male, no. (%) | 12 (31.6) | 11 (29.7) | 10 (30.3) | 8 (21.1) | 7 (25.0) | 13 (50.0) |
Lower education, no. (%) | 4 (10.5) | 2 (5.4) | 2 (6.1) | 4 (10.5) | 8 (28.6) | 5 (19.2) |
Current smoker, no. (%) | 1 (2.6) | 1 (2.7) | 4 (12.1) | 2 (5.3) | 9 (32.1) | 9 (34.6) |
Subspecialty care, no. (%) | 6 (15.8) | 6 (16.2) | 6 (18.2) | 11 (29.0) | 8 (28.6) | 4 (15.4) |
Duration of asthma, mean yr (SD) | 16.8 (11.4) | 15.5 (14.0) | 20.4 (13.3) | 16.1 (12.6) | 15.8 (14.5) | 14.2 (9.9) |
Pre-bronchodilator FEV1 (% pred), mean (SD) | 96.1 (11.4) | 102.3 (13.4) | 89.6 (13.6) | 86.5 (9.6) | 83.2 (14.9) | 70.9 (15.9) |
ACQ, mean (SD) | 0.40 (0.23) | 0.46 (0.18) | 1.08 (0.22) | 1.12 (0.23) | 2.11 (0.55) | 2.07 (0.44) |
ATAQ control index, median (range) | 1 (0-3) | 1 (0-3) | 1 (0-3) | 1 (0-3) | 2 (0-3) | 2.5 (0-4) |
Inhaled corticosteroids, mean μg/day (SD) | 480 (368) | 416 (236) | 475 (377) | 489 (309) | 618 (311) | 623 (316) |
Long-acting β2-agonist, no. (%) | 23 (60.5) | 18 (48.7) | 17 (51.5) | 27 (71.1) | 19 (67.9) | 15 (57.7) |
Leukotriene modifier, no. (%) | 0 (0) | 1 (2.7) | 0 (0) | 2 (5.3) | 2 (7.1) | 0 (0) |